Also trades as: SOON.SW (SIX) · $vol 43M · 0QPY.L (LSE) · $vol 22M · 0QPY.IL (IOB) · $vol 22M · SONVF (OTC) · $vol 0M

$59.95

-0.20 (-0.32%)

Weekly Expected Move ±3.0%

$56 $58 $60 $62 $64

OTC · Healthcare · Medical - Devices · Tech Score Buy · Power 60 · $17.8B mcap · 49M float · 0.034% daily turnover · Short 49% of daily vol

Revenue

$3.6B -6.7% ▼

5Y CAGR: +6.7%

Gross Profit

$2.7B -4.5% ▼

5Y CAGR: +7.7%

Operating Income

$676M -2.3% ▼

5Y CAGR: +3.9%

Net Income

$431M -20.3% ▼

5Y CAGR: -5.8%

EPS (Diluted)

$1.44 -20.2% ▼

5Y CAGR: -4.8%

EBITDA

$931M +0.4% ▲

5Y CAGR: +4.3%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$3.4B	$3.7B	$3.6B	$3.9B	$3.6B
YoY Growth	+29.3%	+11.1%	-3.0%	+6.6%	-6.7%
Cost of Revenue	$943M	$1.1B	$1.0B	$1.1B	$948M
Gross Profit	$2.4B	$2.6B	$2.6B	$2.8B	$2.7B
Gross Margin	72.0%	69.3%	72.3%	72.0%	73.7%
R&D Expenses	$229M	$243M	$261M	$235M	$218M
SG&A Expenses	$1.4B	$1.6B	$1.7B	$1.9B	$1.7B
Operating Expenses	$1.6B	$1.8B	$2.0B	$2.1B	$2.0B
Operating Income	$785M	$762M	$670M	$692M	$676M
Operating Margin	23.3%	20.4%	18.5%	17.9%	18.7%
Interest Expense	$38M	$24M	$28M	$26M	$29M
Income Before Tax	$725M	$712M	$647M	$652M	$642M
Tax Expense	$65M	$57M	$38M	$105M	$96M
Net Income	$649M	$648M	$601M	$540M	$431M
Net Margin	19.3%	17.3%	16.6%	14.0%	11.9%
EPS (Diluted)	$2.07	$2.14	$2.01	$1.81	$1.44
EBITDA	$961M	$979M	$922M	$927M	$931M
Shares Outstanding	314M	302M	299M	299M	303M

Line Item	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2	FY2026 Q4
Revenue	$1.8B	$1.9B	$1.8B	$1.9B	$1.8B	$2.0B	$1.8B	$1.8B
Cost of Revenue	$590M	$558M	$526M	$508M	$515M	$551M	$555M	$439M
Gross Profit	$1.3B	$1.3B	$1.2B	$1.4B	$1.3B	$1.5B	$1.2B	$1.4B
Gross Margin	68.0%	70.5%	70.0%	72.9%	71.9%	72.9%	68.8%	75.5%
R&D Expenses	$119M	$124M	$116M	$143M	$114M	$140M	$111M	$106M
SG&A Expenses	$771M	$815M	$796M	$860M	$908M	$908M	$828M	$915M
Operating Expenses	$890M	$938M	$911M	$1.0B	$1.0B	$1.1B	$939M	$909M
Operating Income	$366M	$395M	$316M	$364M	$279M	$413M	$283M	$446M
Operating Margin	19.8%	20.9%	18.0%	19.4%	15.2%	20.3%	15.9%	24.9%
Interest Expense	$22M	$28M	$22M	$0	$0	$27M	$32M	-$3M
Income Before Tax	$350M	$365M	$294M	$354M	$258M	$394M	$229M	$408M
Tax Expense	$54M	$3M	$44M	-$6M	$47M	$58M	$41M	$55M
Net Income	$292M	$356M	$245M	$356M	$209M	$332M	$185M	$243M
Net Margin	15.8%	18.8%	14.0%	19.0%	11.4%	16.3%	10.4%	13.5%
EPS (Diluted)	$0.96	$1.19	$0.82	$1.19	$0.70	$1.11	$0.62	$0.82
EBITDA	$486M	$536M	$444M	$393M	$417M	$465M	$374M	$557M
Shares Outstanding	305M	300M	299M	299M	299M	299M	298M	302M

SONVY OTC